Jun 1, 2026
Atali dedicated CDMO block could add Rs.250–300 Cr topline
Aarti Pharmalabs Limited — Q4 FY26 Earnings Call (FY ended Mar-2026) 1. Overall Tone of Management: Neutral (slightly Optimistic) Management highlighted “confidence” in momentum from expansions...
